These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2303266)
1. Algorithm for optimal linear model-based control with application to pharmacokinetic model-driven drug delivery. Jacobs JR IEEE Trans Biomed Eng; 1990 Jan; 37(1):107-9. PubMed ID: 2303266 [TBL] [Abstract][Full Text] [Related]
2. A simple analytical solution to the three-compartment pharmacokinetic model suitable for computer-controlled infusion pumps. Bailey JM; Shafer SL IEEE Trans Biomed Eng; 1991 Jun; 38(6):522-5. PubMed ID: 1879840 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of drug infusion pumps under computer control. Connor SB; Quill TJ; Jacobs JR IEEE Trans Biomed Eng; 1992 Sep; 39(9):980-2. PubMed ID: 1473827 [TBL] [Abstract][Full Text] [Related]
4. Algorithm to control "effect compartment" drug concentrations in pharmacokinetic model-driven drug delivery. Jacobs JR; Williams EA IEEE Trans Biomed Eng; 1993 Oct; 40(10):993-9. PubMed ID: 8294136 [TBL] [Abstract][Full Text] [Related]
5. Open loop control of multiple drug effects in anesthesia. Wada DR; Ward DS IEEE Trans Biomed Eng; 1995 Jul; 42(7):666-77. PubMed ID: 7622150 [TBL] [Abstract][Full Text] [Related]
6. The hybrid model: a new pharmacokinetic model for computer-controlled infusion pumps. Wada DR; Ward DS IEEE Trans Biomed Eng; 1994 Feb; 41(2):134-42. PubMed ID: 8026846 [TBL] [Abstract][Full Text] [Related]
7. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model. Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogue. Lee CK; Rowinsky EK; Li J; Giles F; Moore MJ; Hidalgo M; Capparelli E; Jolivet J; Baker SD Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2158-65. PubMed ID: 16609029 [TBL] [Abstract][Full Text] [Related]
9. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics. Marsh RE; Riauka TA; McQuarrie SA J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176 [TBL] [Abstract][Full Text] [Related]
10. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package. Gomeni R; Pineau G; Mentré F Anticancer Res; 1994; 14(6A):2321-6. PubMed ID: 7825966 [TBL] [Abstract][Full Text] [Related]
11. Alfentanil and midazolam: new anesthetic drugs for continuous infusion and an automated method of administration. Reves JG; Glass P; Jacobs JR Mt Sinai J Med; 1989 Mar; 56(2):99-107. PubMed ID: 2501672 [TBL] [Abstract][Full Text] [Related]
12. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics. Mentré F; Mallet A; Steimer JL Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal study. Germani M; Crivori P; Rocchetti M; Burton PS; Wilson AG; Smith ME; Poggesi I Eur J Pharm Sci; 2007 Jul; 31(3-4):190-201. PubMed ID: 17481865 [TBL] [Abstract][Full Text] [Related]
14. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Jelliffe RW; Schumitzky A; Van Guilder M; Liu M; Hu L; Maire P; Gomis P; Barbaut X; Tahani B Ther Drug Monit; 1993 Oct; 15(5):380-93. PubMed ID: 8249044 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171 [TBL] [Abstract][Full Text] [Related]
18. The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume. Lovich MA; Kinnealley ME; Sims NM; Peterfreund RA Anesth Analg; 2006 Apr; 102(4):1147-53. PubMed ID: 16551914 [TBL] [Abstract][Full Text] [Related]
19. Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580). Conley BA; Forrest A; Egorin MJ; Zuhowski EG; Sinibaldi V; Van Echo DA Cancer Res; 1989 Jun; 49(12):3436-40. PubMed ID: 2720696 [TBL] [Abstract][Full Text] [Related]